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Abstract 
Objective 
To analyse the evidence concerning the accuracy of the Mini-Mental State Examination (MMSE) as a 
diagnostic and screening test for the presence of delirium in adults. 
Method 
Two authors searched MEDLINE, PsychINFO and EMBASE from inception till 3/2014. Articles were included 
that investigated the diagnostic validity of the MMSE to detect delirium against standardised criteria. A 
diagnostic validity meta-analysis was conducted. 
Results 
Thirteen studies were included representing 2017 patients in medical settings of whom 29.4% had delirium. 
The meta-analysis revealed the MMSE had an overall sensitivity and specificity estimate of 84.1% and 73.0%, 
but this was 81.1% and 82.8% in a subgroup analysis involving robust high quality studies. Sensitivity was 
unchanged but specificity was 68.4% (95% CI = 50.9% to 83.5%) in studies using a predefined cut-off of <24 to 
signify a case. In high-risk samples where delirium was present in 25% of patients, then the Positive predictive 
value and Negative predictive value would be 50.9% (48.3% - 66.2%) and 93.2% (90.0% - 96.5%). 
Conclusion 
The MMSE cannot be recommended as a case-finding confirmatory test of delirium, but may be used as an 
initial screen to rule out high scorers who are unlikely to have delirium with approximately 93% accuracy. 
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Introduction 
Delirium is a common and pervasive neuropsychiatric condition [1] and the term has been used for acute 
confusion in the International Classification of Diseases version 10 - ICD 10 [2]and the Diagnostic and Statistical 
Manual of Mental Disorders version four- DSM IV.[3] A number of features defining delirium include rapid 
onset of symptoms that tend to fluctuate even during the same day with an altered level of consciousness, 
global disturbance of cognition or perceptual abnormalities with evidence of a physical cause, substance 
intoxication/withdrawal, or multiple etiologies. The presence of delirium causes great concern since people 
affected have worse outcomes including longer hospital stays,[4 5] high risk of dementia,[6]higher rate of 
hospital-acquired complications, such as, falls and pressure sores[7 8] and increased mortality.[9 10 11] In 
addition, delirium complicates between 17-61% of major surgical procedures.[12] 
Many older adults are affected by delirium, for instance up to 50% of hospitalized patients can be diagnosed 
with delirium.[13] The prevalence of delirium on medical wards in hospital is about 3% to 30%[14 15] whilst it 
other research has demonstrated it may affect between 11-42% of general medical inpatients.[13] Delirium is 
also problematic at end of life care and may affect up to 83% of older adults. [12] Within the literature, there 
is a large variation in reporting incidence and prevalence rates of delirium. [16 17 18 19] There are numerous 
reasons that may account for this variability in rates including the source of sample, nature and variety of 
symptoms, diagnostic criteria and methods used. 
Delirium risk is higher in pallaitive care, intensive care and in patients undergoing cardiothoracic surgery, 
emergency orthopedic procedures (repair of a hip fracture), vascular surgery, or cataract removal. [20 21] 
Despite the pronounced prevalence and impact of delirium, healthcare professionals ability recognize it is 
poor with around 50% of cases of delirium going unrecognized.[12 22 23] This is exemplified in one recent 
study where emergency physicians missed delirium in 76% of cases.[24] In another study in an intensive care 
unit, nurses’ detection sensitivity was 27% and specificity 92%, compared with the Confusion Assessment 
Method for ICU (CAM-ICU).[25] The fact that delirium is common, troublesome but under-recognized, 
suggests a role for screening instruments.[26 27] 
In recognition of this, recent guidelines (NICE, 2010)[28] stipulate that all elderly people admitted to hospital 
or in long-term care units should be screened for risk factors of developing delirium and cognitive impairment, 
using a brief cognitive test. Recently, several reviews of screening instruments to detect delirium have been 
published. A recent review of 11 instruments in 25 studies highlighted potentially favourable accuracy for 
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Global Attentiveness Rating (GAR), Memorial Delirium Assessment Scale (MDAS), Delirium Rating Scale-
Revised-98 (DRS-R-98), Clinical Assessment of Confusion (CAC), Delirium Observation Screening Scale (DOSS) 
and Nursing Delirium Screening Scale (Nu-DESC). The Confusion Assessment Method (CAM) was the most 
thoroughly investigated but notable the MMSE was partially omitted from this review. Although the MMSE is 
designed to assess global cognitive impairment, and it currently under licence (pay per use), it may prove 
potentially useful to detect delirium and is already commonly used in a range of clinical settings. Many studies 
have looked at the diagnostic value of the MMSE in cognitive disorders but mostly in context of dementia, not 
delirium.[29] The MMSE has been used extensively in different clinical and non-clinical settings.[30]It is a brief 
test consisting of 20 individual tests covering 11 domains including orientation, registration, attention and 
calculation, recall, naming, repetition, comprehension, writing and construction. Many validation studies exist, 
but most are underpowered and many lack an adequate criterion standard and hence can give a misleading 
impression of accuracy.[31]The MMSE is a valid test of cognitive functions and is reliable for 24 hour and 28 
day assessment for single or multiple raters (Pearson Coefficient 0.877). Internal consistency appears to be 
moderate with Cronbach alpha scores ranging from 0.6 to 0.89.[32 33] However, its utility in detecting 
delirium is uncertain although a large study regarding the MMSE and delirium found a mean MMSE score of 
12.6 in those with delirium and 25.7 in those without.[34] Despite the fact the MMSE is widely used to screen 
for cognitive impairment, its value in diagnosing delirium is uncertain and requires investigation. Thus, the aim 
of this paper was to systematically review and analyze the evidence concerning the accuracy of the MMSE as a 
diagnostic (case-finding) and screening test for the presence of delirium in adults. 
Methods 
This systematic review and meta-analysis was conducted in accordance with the PRISMA guidelines following a 
predetermined protocol. [35]  
Data sources and Search 
Two independent reviewers searched Medline, PsycINFO and Embase abstract databases from inception to 
March 2014. This was supplemented by searches of five full text collections (Science Direct, Ingenta Select, 
Ovid Full Text, Blackwell Online and Wiley Interscience) and the abstract database Web of Knowledge (4.0, ISI). 
In accordance with the protocol, where necessary, authors were contacted directly for primary data. The 
following search terms were used: “(Screen* or test or instrument or measure or tool or diagnos*) and (Mini 
mental state examination or MMSE or Folstein) and (delirium or cogniti*) and (“sensitivity and specificity or 
accuracy or cut-off or receiver operator or ROC or Youden”). 
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Eligibility criteria 
We included studies that examined the diagnostic validity of the MMSE to detect delirium against the 
reference standard according to the Diagnostic and Statistical Manual of Mental Disorders (DSM) of the 
American Psychiatric Association (for example DSM-IV) or International Classification of Diseases (ICD) (for 
example ICD-10) of the World Health Organization criteria. Studies that did not clearly state the comparator to 
be DSM or ICD diagnosis for delirium, or that did not provide sufficient data to be extracted and included in 
the meta-analysis were excluded. We did not place a language restriction upon eligible studies. 
Methodological quality appraisal 
Quality assessment and Risk of bias assessment 
2 authors (BS, AJM) conducted the risk of bias assessment using a four point quality rating and a five point bias 
risk was applied to each study as used in a recent similar study.[36 ] The quality rating score was based on 
study sample size, study design, study attrition, and method of dealing with possible confounders with the 
following scale: 1 = low quality 2 = low-medium quality 3 = medium – high quality 4 = high quality. The bias 
rating score evaluated possible bias in assessments of results as influenced by consideration of setting, 
sampling method, interview method and sampling method. Bias was rated with the following score: 0 = no 
appreciable bias risk 1 = low bias risk 2 = low to medium bias risk 3= medium to high bias risk 4 = high bias risk. 
A composite score of >3 on study quality + <3 on bias score generated seven robust studies. 
Analysis 
An unweighted pooled meta-analysis of suitable studies was conducted, to give overall test accuracy, 
sensitivity, specificity, combined Youden score, positive and negative predictive values (PPV, NPV), positive 
and negative likelihood ratios (LR+, LR-), and positive and negative clinical utility index (CUI+, CUI-). Further 
details are available here www.clinicalutility.co.uk . The clinical utility index (UI) is a proxy for the applied value 
of a test with a qualitative as well as quantitative interpretation.[ [37] 38 39] Clinical utility may be more 
important to clinicians than validity.[40] Clinical utility estimates the clinical value of a diagnostic test taking 
into account both the accuracy of the test and its occurrence. The positive utility index (for rule-in or case-
finding accuracy) is a product of sensitivity and positive predictive value and the negative utility index (for rule-
out or screening accuracy) is a product of Sp x NPV. The interpretation of the clinical utility index is 0.93-1.00 
near perfect value; 0.81-0.92 excellent; 0.64-0.80 good; 0.49-0.63 adequate; 0.36-0.48 poor; and < 0.36 very 
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poor. Publication bias was tested by Harbord method.[41] Comparative accuracy was tested by conducting a 
relative risk comparison of pooled sensitivity and specificity and by comparing overall accuracy at equivalent 
prevalence rates of 25% and 50%. In order to assess the influence of the quality of studies on the observed 
results, we conducted subgroup analysis using most robust (high quality) studies only where the delirium was 
determined by robust interview methods. As the included studies used a variety of cut-off thresholds we also 
conducted a subgroup analysis to establish the observed results differed in studies using a predefined cut off 
of <24 on the MMSE. 
Results 
Part 1 Systematic Review 
We identified 13 valid studies of the MMSE for the detection of delirium in medical settings involving a total of 
2017 patients of whom 29.4% had delirium.  [42]   [43]   [44]   [45]   [46]   [47]   [48]   [49]   [50]   [51]   [52]   
[53]   [54]  Studies were published between 1982 and 2011. The smallest study involved 18 cases of delirium
43
 
whilst the largest had 142 cases.
50 
The prevalence of delirium ranged from 11.7% to 58.3%. All of the studies 
had acceptable methodological quality and none of the studies were deemed to be at high risk of bias. A full 
summary of the included articles details including methodological quality and risk of bias is shown in table 1. 
Anthony et al. (1982) studied 97 patients, who were admitted consecutively to a General medical ward at John 
Hopkins Hospital in 1979, aged above 20 years.
 
[ [55] ] The sample was predominantly female, black, with little 
education and from a socio-economically deprived background. DSM criteria were used as the gold standard, 
applied by a trained psychiatrist. The MMSE was administered within 24 hours of admission to the ward. At a 
cut-off of <24, the MMSE had a sensitivity of 87.0% and a specificity of 82.4% in diagnosing delirium or 
dementia. This study was atypical in that delirium or dementia. Was the gold standard. The authors also 
calculated sensitivity and specificity at various cut-off points on the MMSE. Trzepacz, et al (1988) examined 
108 liver transplantation candidates with end-stage liver disease from gastroenterology service at 
Presbyterian-University Hospital, Pittsburgh.
 
 [56]  They were all English speaking, with 11 or more years of 
education. Subjects were between 17 and 62 years of age. Psychiatric diagnoses were made using DSM-III 
criteria. A MMSE score of less than 24 had a sensitivity of 55.6% and a specificity of 82.2% in detecting 
delirium. Further PPV was 38.5% and NPV 90.2%. Comparatively the trail making test B had 66.7% sensitivity 
and 95.6% specificity. 
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Dyer et al (1994) conducted a prospective study on the diagnosis post-operative delirium comparing the 107 
item Delirium Symptom Interview (DSI) and the MMSE to the Confusion Assessment Method (CAM). [57]  The 
CAM developed in 1990 was used as the gold standard. [58]  The subjects were 60 consecutive patients who 
underwent general, orthopaedic or urologic surgery. DSI, MMSE and CAM were administered pre-operatively 
and post-operatively (day 1 to day 7). 12% of subjects had a pre-operative diagnosis of dementia or depression 
and 58% developed delirium. The MMSE had 77.1% sensitivity, 56.0% specificity 71.1% PPV and 63.6% NPV. 
Comparatively the DSI had 92% sensitivity and 64% specificity. Hart et al (1996) set out to validate two forms 
of Cognitive Test for Delirium (CTD) in medical ICU patients.
 
 [59]  They also compared the performance of CTD 
to the MMSE and investigated whether these tests can be used to differentiate delirium from other mental 
illnesses such as dementia in out-patient setting, depression and schizophrenia in in-patient psychiatry service 
in the Medical College of Virginia. There were less than 30 patients in each group. The DSM IIIR was used as 
the gold standard for diagnosis. An ROC analysis indicated that for both CTD and the MMSE, an optimal cut-off 
score to discriminate delirium from other disorders was <19. At this score, the MMSE had a sensitivity of 100% 
and specificity of 93.8%. Rockwood et al. (1996) compared the MMSE with the DRS in a cross-sectional study 
in 1992 in Ontario, Canada.
 
 [60]  104 inpatients from geriatric medicine and geriatric psychiatry wards of two 
tertiary referral hospitals participated in the study. DSM-III-R was used as the gold standard for diagnosis of 
delirium. The subjects were administered the Delirium Rating Scale (DRS), MMSE, Barthel Index and Blessed 
Dementia Scale.. At a cut off of <24, MMSE showed a sensitivity of 88.5% and specificity of 52.6%. 
Comparatively the DRS had 82% sensitivity and 94% specificity when 10 is set as the cut-point. Rolfson et al. 
(1999) studied a cohort of 71 consecutive patients undergoing elective CABG surgery at a tertiary care hospital 
in Northern Alberta, Canada.
 
 [61]  The primary objective was to assess the validity of the CAM to detect 
delirium but the authors also included data on the MMSE. Patients were followed daily until the 4th post-
operative day. Delirium was diagnosed using the DSM-III-R criteria. The ROC curves were constructed for the 
CAM and MMSE. At a cut-off of <24, the MMSE had a sensitivity of 34.8% and a specificity of 81.3%. 
Comparatively the CAM had 70% sensitivity and 100% specificity. 
Seven studies have been published since 2000. In Grassi et al. (2001) conducted a study which was carried out 
in 6 centres in Italy, including 4 medical oncology wards and 2 palliative care units.
 
 [62]  105 consecutive 
cancer inpatients presenting with a mental status change that were referred to the consultation-liaison 
psychiatric service or palliative care unit were evaluated. The objective was to validate the Italian versions of 
the Delirium Rating Scale (DRS) and the Memorial Delirium Assessment Scale (MDAS). The criterion reference 
was DSM-III-R criteria for delirium. Using a cut-off of <24, the MMSE showed a sensitivity of 95.5% and a 
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specificity of 38.5%, PPV of 72.4% and NPV of 83.3%. Comparatively the MDAS had 68% sensitivity and 94% 
specificity for a cut-off of 13 for delirium. The DRS had 95% sensitivity and 61% specificity for DRS cut-off 10 
and 81% sensitivity and 76% specificity for DRS cut-off 12. Khurana et al. 2002 studied 100 hospitalised 
geriatric general medical patients, aged 65 and above, who were admitted under the Department of Internal 
Medicine, Kasturba Hospital, Manipal, Karnataka. [63]  The patients were assessed within 24 hours or 
admission 61 and then on every 4th day thereafter. The assessment was carried out using the MMSE, CAM, 
DSI against the ICD-10 criteria for delirium. At a cut-off score of <24, the MMSE showed 100% sensitivity and 
45.2% specificity. In comparison, the CAM had 100% sensitivity and 100% specificity. Also, the DSI had 100% 
sensitivity and 90% specificity. Fayers et al (2005) recruited 150 patients, diagnosed with delirium, between 
the ages of 70 and 90, from a general medical unit for somatic diseases in a University Hospital, Norway.
 
 [64]  
Trained nurses administered the MMSE. The authors also studied a separate group of 163 consecutive 
patients who were admitted at the same hospital and of similar age but with no diagnosis of delirium or other 
cognitive impairment. At a cut-off of <24, the MMSE had a sensitivity of 89.4% and specificity of 100% in this 
sample with 100% PPV and 91.6% NPV. O’Keeffe et al. (2005) looked at the value of serial MMSEs in 
diagnosing and monitoring delirium in Ireland.
 
 [65]  In this prospective study 165 consecutive patients aged 65 
and older who were admitted from the accident and emergency department to an acute geriatric medicine 
service were recruited. Two different examiners blind to each other, administered the MMSE to the subjects 
on day 1 and day 6. On the same hospital days, an experienced consultant geriatrician examined the subjects 
and diagnosed delirium using the Confusion Assessment Method (CAM) diagnostic algorithm. A fall of 2 or 
more points on the MMSE was the best determinant for detecting the development of delirium. This change 
score yielded a sensitivity of 91.7% and specificity of 90.0%. A rise of 3 or more points was the best 
determinant for detecting resolution of delirium with a sensitivity of 77% and specificity of 75%. 
Since 2010 a further three studies have been published. Sharma et al. (2011) studied 149 consecutive patients 
who had been referred to the psychiatric department for behavioural abnormalities from various other 
departments in Shree Krishna hospital, Karamsad, Gujarat, over one year. The aim of the study was to assess 
the optimal cut-off for MMSE to detect delirium, using DSM-IV TR as the gold standard. Diagnoses were made 
by a psychiatrist blind to the MMSE score. Using the ROC analysis, the optimal cut-off score of the MMSE was 
24.5, giving a sensitivity of 97% and a specificity of 69% but at <24 sensitivity was 80.6% and specificity 71.8%. 
Franco et al. (2010) examined 291 patients aged over 60 who were hospitalised in three internal medicine 
wards in Clinica Universitaria Bolivariana, Columbia. The patients were assessed within 24 hours of admission 
using Confusion Assessment Method-Spanish (CAM-S) then DRS-R-98 (two-step procedure). Those who scored 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
 
 
‘positive’ were excluded and ‘negative’ were evaluated using the Colombian version of the MMSE, to measure 
global cognitive status. Using the cut-off score for the MMSE <24.5, a sensitivity of 79.4% and a specificity of 
52.1% was found but at < 24 sensitivity was 70.6% and specificity 62.6%. The positive and negative predicted 
values were 20.0% and 94.2%, respectively. However, a limitation of this paper is that the criterion reference 
was two-step procedure and an important consideration is that the authors appear to measure the incidence 
and not the prevalence of delirium. Ringdal et al. (2011) examined the value of the MMSE for detecting 
delirium in 364 over 65 year old Norwegian-speaking subjects. [66]  This was the largest study in the literature. 
Some MMSE questions were modified into Norwegian. The CAM was used as the gold standard with<24 as the 
cut-off point. The MMSE had a sensitivity of 88.2% and a specificity of 54.2% in detecting delirium (PPV was 
33.7% and NPV 94.5%). A summary of the included studies is presented in table 1. 
Part 2 - Meta-analytic Results 
We located 13 studies, all in hospital settings. The total sample size was 2017 of whom 564 giving a pooled 
prevalence of delirium of 27.9% (25.9% to 29.9%); corrected to 29.4% (95% CI = 21.5% to 37.9%) on meta-
analysis. However, this was 31.6% (95% CI = 21.6% to 42.6%) in robust (high quality) studies using interview 
based criteria. The statistical summary of the individual results from each study are presented in table 2. 
Sensitivity and Specificity 
Main Analysis 
Examining sensitivity and specificity, we found a diagnostic validity meta-analysis gave an overall sensitivity 
estimate of 84.1% (95% CI = 75.8% to 90.9%). It was no different in studies using a predefined cut-off of < 24. 
Regarding specificity meta-analysis gave an overall sensitivity estimate of 73.0% (95% CI = 59.6% to 84.5%) (fig. 
1). It was 68.4% (95% CI = 50.9% to 83.5%) in studies using a predefined cut-off of < 24. 
Sub-Analysis (High Quality Studies) 
Sub-analysis including only robust (high quality) studies using interview-based criteria for delirium was 
conducted. Seven such studies had a meta-analytic sensitivity of 81.1% (95% CI = 65.9% to 92.6%) and a 
specificity of 82.8% (95% CI = 64.4% to 95.4%). 
Insert fig. 1 here Bayesian Plot of MMSE accuracy across different prevalence rates 
Positive and Negative Predictive Value 
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Main Analysis 
Using the main analysis for sensitivity and specificity, and assuming delirium was present in 10% of patients, 
then the PPV and NPV would be 25.7% (17.3% - 39.5%) and 97.6% (95.7 – 98.8%), respectively with a positive 
likelihood ratio of 3.11 (1.88 -5.86) and negative likelihood ratio of 0.22 (0.41 – 0.11) (fig. 1). Assuming 
delirium was present in 25% of high-risk patients, then the PPV and NPV would be 50.9% (48.3% - 66.2%) and 
93.2% (90.0% - 96.5%), respectively, with the same likelihood ratios. 
Sub-Analysis (High Quality Studies) 
Using the high quality sub-analysis confined to 7 robust (high quality) studies then sensitivity and specificity, 
and assuming delirium was present in 10% of patients, then the PPV and NPV would be 34.4% (17.1% - 69.1%) 
and 97.5% (94.4 – 99.1%), respectively with a positive likelihood ratio of 4.72 (1.85 -20.1) and negative 
likelihood ratio of 0.23 (0.08 – 0.53). Assuming delirium was present in 25% of high-risk patients, then the PPV 
and NPV would be 61.1% (38.2% - 87.0%) and 92.9% (85.0% - 97.5%), respectively, with the same likelihood 
ratios. 
Clinical Utility 
Main Analysis 
Assuming delirium was present in 10% of patients, then the positive clinical utility would be 0.216 
(qualitatively poor) and the negative clinical utility would be 0.713 (qualitatively good). Assuming delirium was 
present in 25% of patients, then the positive clinical utility would be 0.428 (qualitatively poor) and the 
negative clinical utility would be 0.681 (qualitatively good). 
If the MMSE was used in a modest risk setting (prevalence 10%) then it would likely facilitate in the correct 
detection of 8 delirious patients, missing 2, and correctly ruling out 66 non-delirious patients falsely suggesting 
24. If the MMSE was used in a high risk setting (prevalence 25%) then it would likely facilitate in the correct 
detection of 21 delirious patients, missing 4, and correctly ruling out 55 non-delirious patients but with 20 
false positives. 
Sub-Analysis (High Quality Studies) 
Using the robust (high quality) sub-analysis confined to 7 studies, and assuming delirium was present in 10% of 
patients, then the positive clinical utility would be 0.279 (qualitatively poor) and the negative clinical utility 
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would be 0.808 (qualitatively good). Assuming delirium was present in 25% of patients, then the positive 
clinical utility would be 0.496 (qualitatively poor) and the negative clinical utility would be 0.769 (qualitatively 
good). 
If the MMSE was used in a modest risk setting (prevalence 10%) then it would likely facilitate in the correct 
detection of 8 delirious patients, missing 2, and correctly ruling out 75 non-delirious patients falsely suggesting 
15. If the MMSE was used in a high risk setting (prevalence 25%) then it would likely facilitate in the correct 
detection of 20 delirious patients, missing 5, and correctly ruling out 62 non-delirious patients but with 13 
false positives. 
Discussion 
We located 13 valid diagnostic studies of the MMSE involving 2017 individuals tested for delirium. An inclusive 
approach (including all qualifying studies) led to a sensitivity and specificity estimate for the MMSE of 84.1% 
(95% CI = 75.8% to 90.9%) and 73.0% (95% CI = 59.6% to 84.5%). However, only 7 studies were of deemed to 
be highest quality and used interview based criteria for delirium. In addition, one study used a two-step 
procedure of the CAM in order to find incident delirium cases during hospitalization, that were then quantified 
with the DRS-R98.[54] and this may have influenced the pooled meta-analysis results. Another included 
patients with delirium and/or dementia (although the remainder excluded dementia) [42]. 
Therefore,excluding these and other lower quality studies led to a best estimate of sensitivity and specificity 
refined to 81.1% (95% CI = 65.9% to 92.6%) and 82.8% (95% CI = 64.4% to 95.4%), respectively. Taking this high 
quality study estimate, in both medium risk and high-risk settings the clinical utility of the MMSE was 
qualitatively poor for case-finding. However, in both medium risk and high-risk settings the clinical utility of 
the MMSE was qualitatively good for screening. For example when the prevalence of delirium was 10% the 
MMSE achieved 97.5% NPV. If the MMSE was used in a modest risk setting (prevalence 10%) as an initial 
screening tool then it would likely facilitate in the correct detection of 8 out of 10 delirious patients, missing 2. 
If the MMSE was used in a high risk setting (prevalence 25%) then it would likely facilitate in the correct 
detection of 20 delirious patients, missing about 5 cases. 
The MMSE is the most widely used test of cognitive impairment but its role in assessing delirium has never 
been adequately clarified. The MMSE was designed to assess broad cognitive impairment whereas other tools 
have been specifically designed for screening (e.g. CAM and DSI) or ascertaining the severity of delirium (e.g. 
DI, MDAS and DRS-R-98).[ [67] ] Nevertheless, the MMSE is the most popular tool in clinical practice and the 
one most often used by clinicians to screen for delirium. Clinicians may, however, assume the MMSE is both 
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an adequate screening and case-finding tool. Few studies have offered a head-to-head comparison of focussed 
delirium screens against the MMSE. Assuming replication from at least one indepdent centre is necessary in 
order to make a judgement about such a comparison we could only find a comparison with the delirium rating 
scale (DRS) (2 studies)[46 48] and the confusion assessment method (CAM) (2 studies).[49 51] 
Against the DRS the MMSE had inferior sensitivity and inferior specificity in both studies (DRS SE:90% Sp 82% 
vs MMSE SE 88.5% SP 52.6%)[48] (DRS SE:80% Sp 76% vs MMSE SE 66% SP38.5%)[50]. Against the CAM the 
MMSE appeared to have equal or inferior sensitivity and inferior specificity in both studies (CAM SE:100% Sp 
100% vs MMSE SE 100% SP 45.2%)[51] (CAM SE:70% Sp 100% vs MMSE SE 35% SP 81.3%). [49] Although the 
sample size is low we can state that the MMSE is probably less accurate that its competitors (CAM and DRS) 
when diagnosing delirium. However, it is important to note that the differential effect upon missed negatives 
is very small using either CAM or DRS vs MMSE. In other words for screening purposes the MMSE is probably 
acceptable but for case-finding, competitor tools are prefered. Future studies may clarify if specific domains of 
the MMSE can be used in isolation, for example orientation or spelling. In addition it is likely that accuracy can 
improved by serial testing.
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The under-recognition of delirium can be associated with factors such as the fluctuating nature of delirium, its 
overlap with dementia and depression, the scarcity of formal cognitive assessment in general hospitals by 
routine, under-appreciation of its clinical consequences, and failure to consider the diagnostic importance . 
Non-detection of delirium has been also associated with the high prevalence of the hypoactive form of 
delirium. Four independent risk factors for the under-recognition of delirium by nurses have been identified: 
hypoactive delirium, advanced age, visual impairment, and dementia .[ [68] ] It should also be remembered 
that subtypes of delirium, for example, subsyndromal deliria may be particularly difficult to detect for any 
screening tool. 
The MMSE has some limitations that may have influenced the findings. It has an over-reliance on verbal 
assessment at the expense of non-dominant hemisphere skills and executive functioning, insensitivity to 
frontal executive dysfunction and visuospatial deficits, superficial assessment of memory and language and 
inability to provide qualitative information of cognitive profile.[
53
] Although, the MMSE has high sensitivity and 
specificity with a good positive predictive validity and negative predictive validity it is modestly effective in 
ruling out dementia.
29 39
 Scales for cognitive assessment can be influenced by factors including age, 
educational status, affective changes and fluctuations in cognitive picture, compromising their accuracy. 
Unforunately only two studies (see table 1) examined here looked at younger adults therefore the effect of 
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age remains unaddressed. High inter-observer agreement for the MMSE, the Delirium Symptom Inventory and 
the CAM suggest that they may different but overlapping assessment of delirium. 
Although the brief bedside tools for assessment of cognitive functions have a role, it is important to keep in 
mind that they should not be used to replace a full clinical appraisal to reach a diagnosis of delirium. Hence, 
the MMSE can be used as an aid to ascertain the cognitive status to monitor any improvement or 
deterioration to facilitate the process of making and reviewing a clinical diagnosis and management for early 
intervention for resolution of delirium. 
We conclude that the MMSE should not be used as a case-finding confirmatory test of delirium as it would be 
accurate in 1 in 4 to 1 in 2 cases, but it could be used as an initial screen to rule out those who are unlikely to 
have delirium with approximately 93%-97% accuracy 
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Figure 1. Bayesian Conditional Probability Plot of MMSE Accuracy 
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Pre-test Probability
Po
st
-
te
st
 
Pr
o
ba
bi
lit
y
MMSE+ (HQ)
MMSE- (HQ)
Baseline Probability
MMSE+ (all)
MMSE- (all)
 
Footnote: The Bayesian Conditional Probability Plot shows the positive and negative predictive values for every possible 
prevalence value. 
HQ = high quality studies; All =  all studies 
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Table 1. Methodological Summary of studies 
 
Study 
author 
Diagnosis 
of 
Delirium 
Compariso
ns 
Sample, 
age, gender 
Total 
Study 
Size 
quality 
rating 
score  
bias 
rating 
score  
Mean 
Age 
Gender Setting 
Anthony 
et al 
(1982) 
Delirium 
OR 
Dementia 
DSMIII by 
Psychiatri
st 
none 97 patients 
(37 male) 
46 over 60 
years 
97 3 3 60 years 37 male, 60 
female 
Hospital 
Dyer et 
al (1994) 
Confusion 
Assessme
nt 
Method 
(CAM) 
Delirium 
Symptom 
Interview 
(DSI) 
97% male, 
mean age 
70.1yrs 
60 2 3 70.1 
years 
97% male, Hospital 
Fayers 
et al 
(2005)* 
ICD10 
Delirium 
Brief 4 
items 
MMSE 
80 years, 
58% female 
305 4 1 80 years 42% male Hospital 
Franco 
et al 
(2010) 
Two step: 
CAM-S 
then DRS-
R98 
None 60-99yrs 291 2 2 74.4 
years 
186 
females 
and 105 
males 
Hospital 
Grassi et 
al 
(2001)* 
DSMIIIR 
Delirium  
CAM), the 
DRS, the 
MDAS 
55 males 
67.7 years 
105 3 2 67.7 
years 
55 males Hospital 
Hart et 
al (1996) 
DSMIIIR 
Delirium 
by 
Psychiatri
sts 
Cognitive 
test for 
delirium 
NR 103 2 2 62.5year
s 
42.5% 
female 
Hospital 
(controls 
included 
outpatients) 
Khurana 
et al 
(2002)* 
ICD 10 
DCR 
Delirium 
CAM 
 
Delirium 
Symptom 
Interview 
(DSI) 
65-89 year 100 3 2 65-89 
years 
64% males 
36% 
females 
Hospital 
O'Keeffe 
et al 
(2005)* 
Confusion 
Assessme
nt 
Method 
(CAM) 
none 79 years 160 3 2 79 years NR Hospital 
Ringdal 
et al 
(2011)* 
Confusion 
Assessme
nt 
Method 
(CAM) 
none 84 years, 
76% 
female, 
54% with 
MMSE<24 
364 3 2 Over 65 
years 
76% female Hospital 
patients 
with hip 
fracture 
Rockwo
od et al 
(1996)* 
DSMIIIR 
Delirium 
by 
Psychiatri
sts 
DRS 79years 104 3 2 79years NR Hospital 
Rolfson 
et al 
(1999) 
DSMIIIR 
Delirium 
by 
CAM, CDT 80% male, 
mean age 
71 years 
71 3 3 71 years 80% male, Hospital 
inpatients 
undergoing 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
 
 
Psychiatri
sts 
cardiac 
surgery 
Sharma 
et al 
(2011)* 
DSM-VI TR 
by 
psychiatri
sts 
none >18 years 149 3 2 44 years 87 males 
62 females 
Hospital 
Trzepacz 
et al 
(1988) 
DSMIII 
Delirium 
Trails A, B; 
EEG 
108 
consecutive 
liver 
transplant 
candidates 
108 2 3 41 years 35% male Hospital 
 
Footnote: DRS: delirium rating scale; CAM; Confusion assessment method; CDT: clock drawing test; 
Quality rating scores 1 = low quality 2 = low-medium quality 3 = medium – high quality 4 = high 
quality. Bias rating scores 0 = no appreciable bias risk 1 = low bias risk 2 = low to medium bias risk 
3= medium to high bias risk 4 = high bias risk. *=high quality studies used in subgroup analysis.   
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Table 2. Statistical Summary of studies 
 
Study 
author 
Cut off Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Likelihood 
ratio +ve 
(95% CI) 
Likelihood 
ratio +ve 
 (95% CI) 
Clinical 
Utility Index 
+ve 
Clinical 
Utility 
Index -ve 
Anthony 
et al 
(1982) 
23v24 0.870  
(0.732-
1.00) 
0.824 
(0.738-
0.911) 
0.606 
(0.439 – 
0.773) 
0.953 
(0.901 -
1.00) 
4.95 
(2.95 -8.31) 
0.16 
(0.05 – 0.46) 
0.527 
(0.503-0.551) 
“fair” 
0.786  
(0.780 -
0.791) 
“good” 
Dyer et al 
(1994) 
NR 0.771 
(0.632 – 
0.911) 
0.56 
(0.365 – 
0.755) 
0.711 
(0.566 – 
0.855) 
0.636 
(0.435 -
0.837) 
1.75 
(1.09 – 
2.83) 
0.41 
(0.20 -0.82) 
0.548 
(0.530 -
0.566) 
“fair” 
0.356 
(0.324 – 
0.388) 
“v poor” 
Fayers et 
al (2005) 
23v24 0.894 
(0.844-
0.945) 
1.00 
(1.00-1.00) 
1.00 
(1.00-
1.00) 
0.916 
(0.875 – 
0.957) 
NA 0.11 
(0.07 – 0.17) 
0.894 
(0.893 – 
0.896) 
“good” 
0.916 
(0.915 -
0.917) 
“excellent” 
Franco et 
al (2010) 
<24 0.706 
(0.553 – 
0.859 
0.626 
(0.567 – 
0.686) 
0.20 
(0.128 – 
0.272) 
0.942 
(0.906 – 
0.877) 
1.89 
(1.44 – 
2.47) 
0.47 
(0.28 – 0.80) 
0.141 
(0.133 – 
0.149) 
“v poor” 
0.590 
(0.587 – 
0.593) 
“fair” 
Grassi et 
al (2001) 
23v24 0.955 
(0.904 – 
0.100) 
0.385 
(0.235 – 
0.537) 
0.724 
(0.630 – 
0.818) 
0.833 
(0.661 – 
1.00) 
1.55 
(1.20 -2.00) 
0.12 
(0.04 – 0.38) 
0.691 
(0.685 – 
0.698) 
“good” 
0.321 
(0.294 -
0.347) 
“v poor” 
Hart et al 
(1996) 
18v19 1.00 
(1.00-1.00) 
0.938 
(0.886 – 
0.991) 
0.815 
(0.668 – 
0.961) 
1.00 
(1.00-
1.00) 
16.2 
(6.93 = 
37.9) 
NA 0.815 
(0.801 – 
0.828) 
“Excellent” 
0.938 
(0.937 -
0.940) 
“Excellent” 
Khurana 
et al 
(2002) 
<24 1.00 
(1.00-1.00) 
0.452 
(0.338 – 
0.566) 
0.403 
(0.286 – 
0.520) 
1.00 
(1.00-
1.00) 
1.83 
(1.48 – 
2.25) 
NA 0.403 
(0.387 – 
0.419) 
“Poor” 
0.452 
(0.438 – 
0.466) 
“Poor” 
O'Keeffe 
et al 
(2005) 
Fall of 
2 
points 
0.917 
(0.826 – 
1.00) 
0.900 
(0.847 – 
0.953) 
0.727 
(0.597 – 
0.856) 
0.974 
(0.945 – 
1.00) 
9.17 
(5.36 – 
15.7) 
0.09 
(0.03- 0.27) 
0.666 
(0.653 – 
0.679) 
“Good” 
0.876 
(0.875 – 
0.878) 
“Excellent” 
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Ringdal et 
al (2011) 
23v24 0.882 
(0.809 – 
0.954) 
0.542 
(0.484 – 
0.599) 
0.337 
(0.271 -
0.402) 
0.945 
(0.911 -
0.980) 
1.92 
(1.66 – 
2.24) 
0.22 
(0.12 – 0.41) 
0.297 
(0.291 -
0.302) 
“V Poor” 
0.512 
(0.509 – 
0.515) 
“Fair” 
Rockwood 
et al 
(1996) 
23v24 0.885 
(0.762 – 
1.00) 
0.526 
(0.415 – 
0.636) 
0.383 
(0.260 – 
0.506) 
0.932 
(0.857 – 
1.00) 
1.86 
(1.42 – 
2.45) 
0.22 
(0.07 – 0.65) 
0.339 
(0.322 – 
0.357) 
“V poor” 
0.490 
(0.478 -
0.501) 
“poor” 
Rolfson et 
al (1999) 
23v24 0.348 
(0.153 – 
0.542) 
0.813 
(0.702 – 
0.923) 
0.471 
(0.233 – 
0.708) 
0.722 
(0.603 – 
0.842) 
1.86 
(0.82 – 
4.18) 
0.80 
(0.58 – 1.11) 
0.164 
(0.131 -
0.197) 
“v poor” 
0.587 
(0.575 -
0.599) 
“Fair” 
Sharma et 
al (2011) 
<24.5 0.806 
(0.676 – 
0.935) 
0.717 
(0.635 – 
0.800) 
0.475 
(0.350 – 
0.601) 
0.921 
(0.864 – 
0.977) 
2.84 
(2.04 – 
3.97) 
0.27  
(0.14 -0.53) 
0.383 
(0.368 – 
0.398) 
“poor” 
0.660 
(0.654 – 
0.665) 
“Good” 
Trzepacz 
et al 1988 
NR 0.556 
(0.326 – 
0.785) 
0.822 
(0.743 – 
0.901) 
0.385 
(0.198 – 
0.572) 
0.902 
(0.838 – 
0.967) 
3.13  
(1.70 – 
5.73) 
0.54 
(0.32 – 0.91) 
0.214 
(0.181 -
0.246) 
“v poor” 
0.742 
(0.737 – 
0.747) 
“Good” 
 
Footnote: values calculated from raw data using www.clinicalutility.co.uk calculator. The clinical 
utility index (UI) is a proxy for the applied value of a test with a qualitative as well as quantitative 
interpretation: clinical utility index +ve for case finding and clinical utility index –ve for screening 
